Kesler Norman & Wride LLC Has $1.94 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Kesler Norman & Wride LLC cut its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 5.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,584 shares of the company’s stock after selling 1,166 shares during the quarter. Kesler Norman & Wride LLC’s holdings in Colgate-Palmolive were worth $1,944,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Union Savings Bank raised its position in shares of Colgate-Palmolive by 76.6% in the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after purchasing an additional 134 shares during the period. Avion Wealth increased its position in Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after acquiring an additional 175 shares during the period. Atlantic Edge Private Wealth Management LLC bought a new position in Colgate-Palmolive during the fourth quarter worth $32,000. Core Wealth Advisors Inc. increased its position in Colgate-Palmolive by 56.6% during the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock worth $32,000 after acquiring an additional 146 shares during the period. Finally, McGlone Suttner Wealth Management Inc. bought a new position in Colgate-Palmolive during the fourth quarter worth $34,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Sally Massey sold 12,226 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. 0.37% of the stock is owned by company insiders.

Colgate-Palmolive Trading Down 0.2 %

Shares of CL stock traded down $0.23 on Thursday, reaching $95.89. The company had a trading volume of 2,114,672 shares, compared to its average volume of 4,069,581. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. The stock has a market cap of $78.67 billion, a PE ratio of 30.35, a PEG ratio of 3.54 and a beta of 0.39. The company has a 50-day moving average of $94.31 and a 200-day moving average of $87.95. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $99.08.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The company had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. Colgate-Palmolive’s revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.73 EPS. On average, equities analysts forecast that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.09%. Colgate-Palmolive’s payout ratio is 63.29%.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent research reports. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a research note on Monday, April 29th. Morgan Stanley boosted their target price on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the company an “overweight” rating in a research note on Tuesday, May 28th. Royal Bank of Canada boosted their target price on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research note on Monday, April 29th. Bank of America upped their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, April 29th. Finally, Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, April 16th. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $93.83.

Read Our Latest Report on CL

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.